TY - JOUR
T1 - Low‐Volume Whole Bowel Irrigation and Salicylate Absorption
T2 - A Comparison With Ipecac‐Charcoal
AU - Olsen, Keith M.
AU - Ma, Frank H.
AU - Ackerman, Bruce H.
AU - Stull, Richard E.
PY - 1993
Y1 - 1993
N2 - Study Objective. To evaluate two methods of gastrointestinal decontamination, low‐volume whole bowel irrigation (WBI) and activated charcoal, for their ability to prevent absorption of salicylate. Design. Randomized, two‐phase crossover study. Setting. A clinical research unit in a university‐based teaching hospital. Patients. Six healthy, volunteer men. Interventions. Subjects were assigned to receive 3000 ml WBI or syrup of ipecac 30 ml followed by activated charcoal 50 g in sorbitol, and were crossed over to the other treatment phase after 1 week. All treatments began 30 minutes after ingestion of 3.25 g aspirin. Urine was collected over 24 hours for analysis of total urinary excretion of salicylate. Serial blood samples were collected for salicylate determination and were subjected to pharmacokinetic analysis. Measurements and Main Results. Mean ± SD recovery of salicylate were WBI 48.6 ± 5.4% and ipecac‐charcoal 37.0 ± 2.6% from urine (p<0.01). Conclusion. Ipecac‐charcoal produced a significantly lower salicylate absorption (peak concentration, AUC) than WBI (p<0.01) and thus was superior to low‐volume WBI. 1993 Pharmacotherapy Publications Inc.
AB - Study Objective. To evaluate two methods of gastrointestinal decontamination, low‐volume whole bowel irrigation (WBI) and activated charcoal, for their ability to prevent absorption of salicylate. Design. Randomized, two‐phase crossover study. Setting. A clinical research unit in a university‐based teaching hospital. Patients. Six healthy, volunteer men. Interventions. Subjects were assigned to receive 3000 ml WBI or syrup of ipecac 30 ml followed by activated charcoal 50 g in sorbitol, and were crossed over to the other treatment phase after 1 week. All treatments began 30 minutes after ingestion of 3.25 g aspirin. Urine was collected over 24 hours for analysis of total urinary excretion of salicylate. Serial blood samples were collected for salicylate determination and were subjected to pharmacokinetic analysis. Measurements and Main Results. Mean ± SD recovery of salicylate were WBI 48.6 ± 5.4% and ipecac‐charcoal 37.0 ± 2.6% from urine (p<0.01). Conclusion. Ipecac‐charcoal produced a significantly lower salicylate absorption (peak concentration, AUC) than WBI (p<0.01) and thus was superior to low‐volume WBI. 1993 Pharmacotherapy Publications Inc.
UR - http://www.scopus.com/inward/record.url?scp=0027265120&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027265120&partnerID=8YFLogxK
U2 - 10.1002/j.1875-9114.1993.tb02729.x
DO - 10.1002/j.1875-9114.1993.tb02729.x
M3 - Article
C2 - 8100628
AN - SCOPUS:0027265120
SN - 0277-0008
VL - 13
SP - 229
EP - 232
JO - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
JF - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
IS - 3
ER -